Abstract
Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Current Pharmaceutical Biotechnology
Title: Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus
Volume: 12 Issue: 8
Author(s): Min Li, Arunachalam Muthaiyan, Corliss A. O'Bryan, John E. Gustafson, Y. Li, Philip G. Crandall and Steven C. Ricke
Affiliation:
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Abstract: Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Export Options
About this article
Cite this article as:
Li Min, Muthaiyan Arunachalam, A. O'Bryan Corliss, E. Gustafson John, Li Y., G. Crandall Philip and C. Ricke Steven, Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus, Current Pharmaceutical Biotechnology 2011; 12 (8) . https://dx.doi.org/10.2174/138920111796117283
DOI https://dx.doi.org/10.2174/138920111796117283 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Antimicrobial Strategies Effective Against Infectious Bacterial Biofilms
Current Medicinal Chemistry Medicinal Use of Lincosamides and Microbial Resistance to Them
Anti-Infective Agents in Medicinal Chemistry Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women
Current Medicinal Chemistry Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae
Current Pharmaceutical Biotechnology Driving Forces of Mechanisms Regulating Oxacillin-Resistance Phenotypes of MRSA: Truly Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates also Exist
Current Pharmaceutical Design Polyproline and Triple Helix Motifs in Host-Pathogen Recognition
Current Protein & Peptide Science Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology β-Lactams in the New Millennium. Part-II: Cephems, Oxacephems, Penams and Sulbactam
Mini-Reviews in Medicinal Chemistry Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis
CNS & Neurological Disorders - Drug Targets The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design Recent Developments in Antithrombotic Therapy: Will Sodium Warfarin Be a Drug of the Past?
Recent Patents on Cardiovascular Drug Discovery Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Current Pharmaceutical Design The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals Virtual Screening for the Development of New Effective Compounds Against Staphylococcus aureus
Current Medicinal Chemistry Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
Current Cardiology Reviews Waste Material of Propolis as a Film Forming Agent Intended to Modify the Metronidazole Release: Preparation and Characterization
Current Drug Delivery Chemistry and Pharmacology of Neglected Helminthic Diseases
Current Medicinal Chemistry